(Q46690999)
Statements
1 reference
Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy (English)
1 reference
Vu H Duong
1 reference
Michael V Jaglal
1 reference
Ling Zhang
1 reference
Vishakha Kale
1 reference
Jeffrey E Lancet
1 reference
Rami S Komrokji
1 reference
Alan F List
1 reference
27 December 2012
1 reference
1 reference
37
1 reference
3
1 reference
300-304
1 reference